Mutual Matters

FAQs - Texting or Emailing Patients

Posted by Carrie Lowe, JD on Apr 12, 2018 11:58:00 AM

Can I text or email my patients?

Yes, healthcare providers can communicate with patients via text messages, but only if:

Read More

Topics: Patient Care and Interaction

ALERT – New Florida Opioid Law

Posted by Carrie Lowe, JD on Apr 5, 2018 12:05:00 PM

By Joshua D. Aubuchon, Nichole Lydon and Carrie Lowe

Read More

Topics: Patient Care and Interaction

New CMS Policy Prohibits Texting Orders

Posted by Carrie Lowe, JD on Mar 15, 2018 11:57:00 AM

On December 28, 2017, the Center for Medicare and Medicaid Services (CMS) announced that texting patient information among healthcare providers is acceptable if done through a secure platform, but the texting of orders is prohibited - even if the orders are encrypted.

Read More

Topics: Employment Issues and Workplace Management, Contracts and Business Relationships

FDA Alert: Prescibing Clarithromycin to Patients with Heart Disease

Posted by Dana N. Taylor, MHA, CPHRM, CPPS on Mar 6, 2018 12:00:00 PM

A new FDA alert issues a warning about prescribing the antibiotic clarithromycin (Biaxin) for patients with heart disease due to a potential increased risk of cardiac problems or death that can occur years later. The FDA recommendation is based upon a review of a ten-year follow-up study of patients with heart disease from a large clinical trial. 

Read More

Topics: Patient Care and Interaction

New Budget Deal Includes Significant Healthcare Provisions

Posted by Emma Cecil, JD on Mar 1, 2018 12:45:00 PM

On February 9, 2018, Congress passed and the President signed into law the Bipartisan Budget Act of 2018 (BBA), a comprehensive piece of legislation that provides for a two-year budget agreement and funds the federal government through March 23, 2018. The BBA’s sweeping measures address federal spending for the military, domestic programs, and disaster relief, and contain several provisions impacting federal healthcare programs. Among other things, the BBA:

Read More

Topics: Billing and Reimbursement

HIPAA Breach Reporting Deadline is Almost Here

Posted by Emma Cecil, JD on Feb 22, 2018 1:00:00 PM

Healthcare providers and other HIPAA covered entities have until March 1, 2018 to report to the U.S. Department of Health & Human Services’ Office for Civil Rights (“OCR”) breaches involving fewer than 500 individuals that were discovered in the 2017 calendar year. Although covered entities must notify HHS of breaches involving 500 or more individuals within 60 days of the date the breach is discovered, breaches affecting fewer than 500 individuals may be documented in a breach log and reported on an annual basis. Covered entities who elect to report smaller breaches on an annual basis must make their submissions to HHS through the OCR online portal within 60 days after the end of the year in which the breaches were discovered, giving them a March 1, 2018 notification deadline.

Read More

Topics: HIPAA and Cybersecurity

Complicated Communication: Discussing Unexpected Outcomes 

Posted by Marshaleen King, MD on Feb 8, 2018 12:05:00 PM

Case Scenario

A 32-year-old woman underwent emergency cesarean section due to fetal bradycardia. Her C-section was complicated by an injury to her bladder which was repaired immediately by her obstetrician.

Read More

Topics: Patient Care and Interaction

A New Year Brings New Cyber Security Threats

Posted by Sanjay Narula on Feb 2, 2018 12:03:00 PM

R_DoctoriPad.jpgThere is never a dull moment in the world of cyber security.

In 2017:

  • WannaCry, Petya, Not Petya, became household names
  • 143 million personal records containing highly sensitive information leaked in a data breach at Equifax
  • Yahoo revealed that every single email account, (3 billion in total), were impacted by the 2013 data breach
  • Microsoft was compelled to release security patches for Windows XP and Windows server 2003 to mitigate risks presented by the EternalBlue exploits
Read More

Topics: HIPAA and Cybersecurity

FDA Alert: Betrixaban Approved for Extended VTE

Posted by Marshaleen King, MD on Jan 25, 2018 1:00:00 PM

MMIC_Pill_bottles_close up.jpg

In 2017, betrixaban, a factor Xa inhibitor, became the first drug to be approved by the U.S. Food and Drug Administration (FDA) for hospital and extended duration (35 to 42 days) VTE prophylaxis.

Read More

Topics: Patient Care and Interaction

Medicare Update - Appropriate Use Criteria 

Posted by Hoyt Torras, MPA, MHA on Jan 19, 2018 12:05:00 PM

This summary is based primarily on the Medicare Physician Fee Schedule CY2018, Final Rule – Published in the Federal Register November 15, 2017.

Read More

Topics: Billing and Reimbursement

Subscribe to Email Updates

What other resources would you like us to provide?

Sharing Insight on Mutual Matters

As one of the leading mutual providers of Medical Professional Liability insurance, we're here to help all healthcare professionals with the challenges they face on a daily basis. The topics we cover include: 

  • Healthcare legislation updates
  • Patient safety guidance
  • Practice and hospital management advice
  • and more. 

Recent Posts